A cura do cancao a-o petto a depende da tanti fattoî comme o stadio do cancao, o tipo de cancao, a sanitæ generale da paçiente e e preferense personæ.
Çerte opçioin de trattamento commun includdan:
1. Chirurgia: a consciste inta rimoçion do tumô e do tesciuo d'in gio.
Gh'é di tipi despægi de operaçion, compreisa a lumpectomia, a mastectomia e a remoçion di linfonodi.
2. Radioterapia: a deuvia unna radiaçion de erta energia pe ammassâ e çellole do cancao e redue i tumori.
O ven deuviou de spesso dòppo l'operaçion pe ammassâ tutte e çellole do cancao che ghe son arrestou.
3. chemioterapia: a l"à da fâ co-o deuviâ de meixime pe ammassâ e çellole do cancao.
O peu ëse dæto pe via intravenosa ò pe via orale e o ven deuviou de spesso pe redue i tumori avanti de un intervento chirurgico ò pe ammassâ tutte e çellole cancerose che ghe n'é arrestou dòppo l'intervento.
4. terapia ormonale: sto chì o ven deuviou pe-i cancri a-o petto che an di recettori ormonali poxitivi e o fonçionn-a bloccando i ormoni che alimentan a crescita de çellole de cancro.
5. terapia mirâ: sto chì o deuvia di farmachi che se çernan de molecole specifiche coinvòlte inta crescita e diffusion de çellole do cancao.
6. Immunoterapia: Sta chì a l'aggiutta o scistema immunitäio à reconosce e attaccâ e çellole do cancao.
7. de preuva cliniche: i paçienti peuan ascì consciderâ de parteçipâ à de preuva cliniche pe avei accesso à de terapie neuve e sperimentali.
L'é importante discutte e megio opçioin de trattamento con un gruppo de sanitæ, perché o progetto de trattamento o saià adattou a-e neçescitæ e a-e circostanse specifiche de l'individuo.
Pe de ciù, a cura de suppòrto comme a gestion da-o dô, o suppòrto emotivo e a guidda nutriçionâ peuan ëse ascì parte do progetto de tratamento.
Kumar L, Baldi A, Verma S, Utreja P: Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer. Pharm Nanotechnol. 2018, 6 (2): 94-110.
Mehrgou A, Akouchekian M: Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease. J Res Med Sci. 2017, 22 (): 130.
Ng AK, Travis LB: Radiation therapy and breast cancer risk. J Natl Compr Canc Netw. 2009, 7 (10): 1121-8.
Ligresti G, Libra M, Militello L, Clementi S, Donia M, Imbesi R, Malaponte G, Cappellani A, McCubrey JA, Stivala F: Breast cancer: Molecular basis and therapeutic strategies (Review). Mol Med Rep. , 1 (4): 451-8.
Bricou A, Barranger E: Response to the article by Evangelista et al.: Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting. Breast Cancer Res Treat 2014. Breast Cancer Res Treat. 2014, 148 (1): 231-2.
Daniyal A, Santoso I, Gunawan NHP, Barliana MI, Abdulah R: Genetic Influences in Breast Cancer Drug Resistance. Breast Cancer (Dove Med Press). 2021, 13 (): 59-85.
Li X, Bu X: Progress in Vaccine Therapies for Breast Cancer. Adv Exp Med Biol. 2017, 1026 (): 315-330.
['Disclaimer: medicâ']
["Sto scito web o l'é fornio solo pe di propòxiti educativi e informativi e o no costituisce un conseggio medico ò serviççi profescionæ."]
["L'informaçion fornia a no dovieiva ëse deuviâ pe diagnosticâ ò curâ un problema de sanitæ ò unna mouttia, e quelli che çercan un conseggio medico personale devan consultâ un mego licençiou."]
['Pe piaxei, ti ti o sæ che a ræ neurale ch\'a genera de respòste a-e domande a l"é inprecisa sorviatutto quande se tratta de contegnui numerichi, comme o numero de persoñe che gh\'é stæto diagnosticou unna mouttia particolâ.']
["çercâ delongo o conseggio do teu mego ò de un atro fornitô de sanitæ qualificou in sciâ condiçion medica. no trascurâ mai o conseggio de un mego profescionista ò ritardâ a çercâlo apreuvo à quarcösa che ti t'æ lezuo in sce sto scito web."]
['Disclaimer: copyright']
["O Digital Millennium Copyright Act do 1998, 17 U.S.C. § 512 (o DMCA) o fornisce un ricorso pe-i propietäi de copyright che creddan che o materiale ch'o l'appare in sce Internet o l'infrange i seu driti segondo a leze di copyright di Stati Unii. "]
["Se ti ti creddi de bonn-a fede che un qualunque contegnûo ò materiale misso a dispoxiçion in connescion co-o nòstro scito web ò serviççi o l'infrange i teu driti d'autô, ti (ò o teu agente) ti peu mandâne 'na notifica con domandâ che o contegnûo ò o materiale o segge levòu ò che l'acesso o segge bloccou."]
['E comunicaçioin devan vegnî mandæ pe iscritto pe email (veddi a seçion "Contact" pe l\'indirissô email).']
["O DMCA o l'exige che a teu notifica de presunta violaçion di driti d'autô a contégne e informaçioìn chi sótta: (1) descriçion de l'euvia protetta da driti d'autô ch'a l'é l'oggetto da presunta violaçion; (2) descriçion do contegnûo che se presumibilmente o l'é a violaçion e informaçioìn suffiçienti pe permette a niatri de localizzâlo; (3) informaçioìn de contatto pe ti, compreiso o teu indirìsso, o teu nómme de telefonin e o teu indirìsso email; (4) 'na teu affermaçion che ti ti credi de bonn-a fêde che o contegnûo into mòddo reclamòu o no segge autorizòu da-o propietâio di driti d'autô, ò da-o seu agente, ò da l'açion de quæ se segge leze; "]
["(5) unna declaraçion da parte teu, firmâ sotta pena de perjurio, che e informaçioin inta notifica son accuræ e che ti gh'æ l'autoritæ de fâ respettâ i driti d'autô che se sostegne che seggian stæti violati;"]
["e (6) unna firma fixica ò elettrònica do propietäio do drito d'autô ò de unna persoña autorisâ à agî a-o seu nomme."]
["Se no ti inserisci tutte e informaçioin chì de d'ato, o peu comportâ un retardo into trattamento da teu lamentela."]
['Contatto']
["Pe piaxei manda 'na mail con ògni domanda/suggerimento."]
How to treat breast cancer?
The treatment for breast cancer depends on various factors such as the stage of cancer, the type of cancer, the patient's overall health, and personal preferences.
Some common treatment options include:
1. Surgery: This involves removing the tumor and surrounding tissue.
There are different types of surgery, including lumpectomy, mastectomy, and lymph node removal.
2. Radiation therapy: This uses high-energy radiation to kill cancer cells and shrink tumors.
It is often used after surgery to kill any remaining cancer cells.
3. Chemotherapy: This involves using drugs to kill cancer cells.
It can be given intravenously or or orally and is often used to shrink tumors before surgery or to kill any remaining cancer cells after surgery.
4. Hormone therapy: This is used for hormone-receptor-positive breast cancers and works by blocking the hormones that fuel the growth of cancer cells.
5. Targeted therapy: This uses drugs that target specific molecules involved in the growth and spread of cancer cells.
6. Immunotherapy: This helps the immune system recognize and attack cancer cells.
7. Clinical trials: Patients may also consider participating in clinical trials to access new and experimental treatments.
It is important to discuss the best treatment options with a healthcare team, as the treatment plan will be tailored to the individual's specific needs and circumstances.
Additionally, supportive care such as pain management, emotional support, and nutritional guidance may also be part of the treatment plan.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['In sciâ']
['BioMedLib o deuvia di computer automatizzæ (algoritmi de machine learning) pe generâ de cobbie de domande e respòste.']
['Comensemmo con 35 mioin de pubricaçioin biomediche de PubMed/Medline.']
